Blanc-Petitjean Pauline, Jézequel Magali, Manunta Andrea, Olivari-Philiponnet Camille, Samson Emmanuelle, Bajeux Emma
Department of Epidemiology and Public Health, Rennes University Hospital, Rennes 1 University, Rennes, France.
Centre de référence spina bifida et dysraphismes, Rennes University Hospital, France.
Prev Med Rep. 2023 Dec 17;38:102568. doi: 10.1016/j.pmedr.2023.102568. eCollection 2024 Feb.
Folic acid insufficiency is an important risk factor for congenital neural tube defects. Despite recommendations and national campaigns, the proportion of women taking folic acid in the peri-conceptional period remains insufficient worldwide. We describe in this study the proportion of peri-conceptional folic acid supplementation use and its determinants among a population of hospital workers during the course of a prevention campaign. We performed a single-center cross sectional study in a university hospital in France. Data were collected during 2 months in 2019 by an online questionnaire sent to all professionals. We collected information about folic acid supplementation use, its modalities (form, period, frequency and dosage) and reason for initiating or not supplementation. Response rate was 11.4 % (n = 1,075/9,447). Among the 748 women who reported at least one pregnancy, 72.7 % (95 % CI: 69.4-76.0 %) reported taking folic acid during their last pregnancy. Main reason for initiating supplementation was information given by a health professional (87.8 %), especially by gynaecologists-obstetricians. Principal factors associated with folic acid supplementation use were age between 25 and 35 years, high level of education and recent pregnancy. Folic acid supplementation use is still not systematic before and during pregnancy, even among health professionals. There is a case for mandatory folic acid fortification for the French general population.
叶酸不足是先天性神经管缺陷的一个重要风险因素。尽管有相关建议和全国性宣传活动,但在全球范围内,孕期服用叶酸的女性比例仍然不足。在本研究中,我们描述了在一项预防活动期间,医院工作人员群体中孕期叶酸补充剂的使用比例及其决定因素。我们在法国一家大学医院进行了一项单中心横断面研究。2019年,通过向所有专业人员发送在线问卷,在两个月内收集数据。我们收集了有关叶酸补充剂使用情况、其服用方式(剂型、时期、频率和剂量)以及开始或不开始补充的原因等信息。回复率为11.4%(n = 1075/9447)。在报告至少有一次怀孕的748名女性中,72.7%(95%CI:69.4 - 76.0%)报告在最后一次怀孕时服用了叶酸。开始补充叶酸的主要原因是医疗专业人员提供的信息(87.8%),尤其是妇产科医生。与叶酸补充剂使用相关的主要因素是年龄在25至35岁之间、教育程度高以及近期怀孕。即使在医疗专业人员中,孕期和孕前叶酸补充剂的使用仍不普遍。有必要对法国普通人群强制进行叶酸强化。